Life Stage Nutrition Premix Manufacturer

Yes. Our Stage 1 infant formula premix is formulated to CODEX STAN 72 as revised 2007 and amended 2019 — covering the vitamin, mineral, and trace element minimums and maximums for products targeting infants 0–6 months. Stage 2 (6–12 months) and growing-up milk premixes (12–36 months) are formulated to CODEX STAN 156 as revised 2017. Full regulatory submission documentation is provided with each formulation, including formulation rationale referenced against CODEX nutrient tables.

Infant-grade premixes are manufactured on dedicated lines with full allergen segregation protocols. This includes separate equipment, dedicated air-handling circuits, cleaning validation procedures specific to the infant production zone, and environmental monitoring programmes. Allergen declarations for each raw material input are verified at goods-in, and allergen risk assessments are maintained in our quality management system and available for client and regulatory review.

Our maternal and prenatal premixes are formulated with vitamin D3 levels aligned to WHO antenatal care guidelines and applicable market RDA targets — typically 400–600 IU per daily serving for supplement formats, with formulation adjusted for the target market regulatory framework (FSSAI, EFSA, FDA). We can formulate to specific target potencies and provide stability data confirming label claim is maintained throughout the stated shelf life.

Yes. Our infant and growing-up milk premixes are specifically formulated for DHA and ARA compatibility. Antioxidant systems within the premix are adjusted to protect sensitive omega fatty acid encapsulates — preventing lipid oxidation during blending and throughout shelf life. We conduct oxidative stability testing in co-processed formats to confirm that the premix does not accelerate DHA/ARA degradation in the finished formula.

Our growing-up milk premixes are used by manufacturers supplying India, South Asia, the Middle East, Southeast Asia, and Africa — covering FSSAI infant food regulations, CODEX STAN 156, and applicable national regulatory frameworks for the target market. We provide market-specific formulation documentation, and can develop variants calibrated to individual country RDA targets and regulatory nutrient ranges where they differ from CODEX.

Senior nutrition premixes address age-related absorption changes and the specific micronutrient gaps most prevalent in the 60+ population — notably vitamin D3 (often formulated at higher levels due to reduced skin synthesis capacity), methylcobalamin (the active form of B12, preferred given reduced intrinsic factor production with age), calcium, and antioxidant vitamins E and C. We formulate senior premixes for ONS, powder, and tablet formats, with ingredient forms selected for digestibility and bioavailability in older adults.